Retroviral-vector-based vaccines |
Stable integration into the host genome; high gene transduction efficiency |
Once infected, the likelihood of eliminating the virus is low |
[86] |
Herpes simplex virus vector vaccine |
Enhances cellular and humoral immunity; Induces lasting immune response. |
High cytotoxicity |
[75,88,89] |
Adenovirus vector vaccine |
Induces moderate innate immunity; high thermal stability |
Cause acute hepatotoxicity |
[90,91,92] |
Lentiviral vector vaccine |
Induces durable humoral immunity |
Insertional mutagenesis; yields low viral titers; easily degradable |
[93,94] |